Clinical trial
Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer)
NCT04611035 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer)
- Lead sponsor
- National University Hospital, Singapore
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 20, 2020
- Completion date
- January 31, 2023
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal cancer